CREO.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:21):

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom...

Stats
Šios dienos apimtis	302 638
Vidutinė apimtis	805 099
Rinkos kapitalizacija	131.04M
EPS	£0 ( 2024-04-23 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-3.30
ATR14	£0.217 (0.60%)

Tūris Koreliacija

Ilgas: 0.17 (neutral)

Trumpas: -0.05 (neutral)

Signal:(48.619) Neutral

Creo Medical Group PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
AERI.L	0.824

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Creo Medical Group PLC Koreliacija - Valiuta/Žaliavos

-0.49
( neutral )

-0.22
( neutral )

0.00
( neutral )

-0.38
( neutral )

0.03
( neutral )

0.15
( neutral )

Creo Medical Group PLC Finansinės ataskaitos

Annual	2022
Pajamos:	£27.17M
Bruto pelnas:	£10.01M (36.84 %)
EPS:	£-0.140

FY	2022
Pajamos:	£27.17M
Bruto pelnas:	£10.01M (36.84 %)
EPS:	£-0.140

FY	2021
Pajamos:	£25.16M
Bruto pelnas:	£11.59M (46.04 %)
EPS:	£-0.158

FY	2020
Pajamos:	£9.43M
Bruto pelnas:	£4.03M (42.79 %)
EPS:	£-0.130

Financial Reports:

No articles found.

Creo Medical Group PLC

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.